MEDICATION AS POSSIBILITY OF FUNCTIONAL REHABILITATION’S IMPROVEMENT IN STROKE PATIENTS

Download full text PDF
Issue: 
9
Year: 
2015

Professor V. Kovalchuck (1), MD; E. Tokareva (2) 1 -Medical Rehabilitation Centre N.A. Semashko City Hospital Thirty-Eight, Saint Petersburg; 2 -Sixth City Hospital, Sevastopol

An influence of Dusopharm on functional rehabilitation in stroke patients has been studied. We’ve analysed the results of treatment of 650 ischemic stroke patients. The functional rehabilitation was followed up using Barthel, Lindmark, Scandinavian and Merton and Sutton scales, psychoemotional condition – Beck Depression Questionnaire and Wakefield Depression Scale, quality of life – Sickness Impact Profile. The results of the study revealed that the use of Dusopharm was well founded in the treatment of stroke patients for increase a functional rehabilitation and improvement of psychoemotional condition and the quality of life.
Keywords: 
stroke
rehabilitation
dusopharm

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Vilenskij B.S. Insul't / SPb: Meditsinskoe informatsionnoe agentstvo, 1995; 287 s.
  2. Geht A.B. Ishemicheskij insul't: vtorichnaja profilaktika i osnovnye napravlenija farmakoterapii v vosstanovitel'nom periode // Consilium medicum. – 2001; 5: 227–32.
  3. Demidenko T.D., Ermakova N.G. Osnovy reabilitatsii nevrologicheskih bol'nyh / SPb: Foliant, 2004; 300 s.
  4. Kamaeva O.V., Monro P. Mul'tidistsiplinarnyj podhod v vedenii i rannej reabilitatsii nevrologicheskih bol'nyh: metod. posob. Pod red. A.A. Skoromtsa / SPb, 2003; 20 s.
  5. Koval'chuk V.V. Vlijanie meksidola na nevrologicheskij defitsit, sotsial'no-bytovuju adaptatsiju i sindromy neglekta i ottlakivanija u patsientov posle insul'ta // Zhurn. nevrol. i psihiat. im. S.S. Korsakova. – 2011; 2: 52–7.
  6. Koval'chuk V.V. Otsenka effektivnosti i bezopasnosti Midokalma v rannem vosstanovitel'nom periode insul'ta // Zhurn. nevrol. i psihiat. im. S.S. Korsakova. – 2013; 4: 35–40.
  7. Koval'chuk V.V., Bogatyreva M.D., Minnullin T.I. Sovremennye aspekty reabilitatsii bol'nyh, perenesshih insul't // Zhurn. nevrol. i psihiat. im. S.S. Korsakova. – 2014; 6: 101–5.
  8. Kuznetsov M.R., Kosyh I.V., Jumin S.M. i dr. Primenenie naftidrofurila v angiologii // Angiologija i sosudistaja hirurgija. – 2014; 4: 27–35.
  9. Skvortsova V.I., Chazova I.E., Stahovskaja L.V. i dr. Pervichnaja profilaktika insul'ta // Kachestvo zhizni. Meditsina. – 2006; 2: 72–7.
  10. Alanen A., Kallio T., Lehto I. et al. The effect of naftidrofuryl on red blood cell aggregation detected in vitro with ultrasound // J. Cardiovasc. Pharmacol. – 1990; 16 (suppl. 3): 33–5.
  11. Bergner M., Bobbitt R., Carter W. et al. The Sickness Impact Profile: development and final revision of a health status measure // Med. Care. – 1981; 19: 787–805.
  12. Capon A., Lehert P., Opsomer L. Naftidrofuryl in the treatment of subacute stroke // J. Cardiovasc. Pharmacol. – 1990; 16 (suppl. 3): 62–6.
  13. Davies A., Magee T., Baird R. et al. Praxile as an alternative for the augmentation of femoro-distal bypass blood flow // Eur. J. Vase Surg. – 1992; 6: 299–301.
  14. Grossmann W., Standl A., May U. et al. Naftidrofuryl in the treatment of mild senile dementia. A double-blind study // Pharmacopsychiatry. – 1990; 23: 265–73.
  15. Herrmann K., Kreuzer H. Effect of serotonergic antagonism on local responses to an acute and selective endothelial trauma in vivo // J. Cardiovasc. Pharmacol. – 1990; 16 (suppl. 3): 40–4.
  16. Hickie I., Lloyd A., Wakefield D. et al. The psychiatric status of patients with the chronic fatigue syndrome // Br. J. Psychiatry. – 1990; 156: 534–40.
  17. House A., Dennis M., Hawton K. et al. Methods of identifying mood disorders in stroke patients: experience in the Oxfordshire Community Stroke Project // Age Ageing. – 1989; 21: 371–9.
  18. Kwantabisa N. Occupational therapy ADL checklist self maintenance // Merton and Sutton Community NHS Trust. Stroke Rehabilitation Team Protocol / London, 1999; p. 7–9.
  19. Lepetit J., Dumond D., Gros J. Controle de l’activite du naftidrofuryl a la phase aigue des AVC par I’echopulsogra- phie transcerebrale // Psychol. Med. – 1992; 24: 975–82.
  20. Lindmark B. Evaluation of functional capacity after stroke with special emphasis on motor function and activities of daily living // Scand. J. Rehabil. Med. – 1988; 21: 1–40.
  21. Machoney F., Barthel D. Functional evalution: the Barthel Index // Md. State Med. J. – 1965; 14: 61–5.
  22. Meynaud A., Grand M., Fontaine L. Effect of naftidrofuryl upon energy metabolism of the brain // Arzneimittelfor-schung. – 1973; 23: 1431–6.
  23. Möller H., Hartmann A., Kessler C. et al. Naftidrofuryl in the treatment of vascular dementia // Eur. Arch. Psychiatry Clin. Neurosci. – 2001; 251: 247–54.
  24. Scandinavian Stroke Study Group. Multicenter trial of hemodilution in ischemic stroke: background and study protocol // Stroke. – 1985; 16: 885–90.